X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: John H. Strickler, Fatima A. Rangwala, Christel Rushing, Donna Niedzwiecki, Ivy Altomare, Hope Elizabeth Uronis, Shiaowen David Hsu, Yousuf Zafar, Michael Morse, David Z. Chang, James Leroy Wells, Kimberly L. Blackwell, P. Kelly Marcom, Anna Renee Webb, Evan Dropkin, Christy Arrowood, Herbert Hurwitz
Institutions: Duke Medical Center, Virginia Oncology Associates
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590027625
